Below are the top 10 Medical Equipment stocks with highest upside potential, based on the difference between current price and Wall Street analysts' average target price.
Unilife Corp (NASDAQ:UNIS) has the 1st highest upside potential in this segment of the market. Its upside is 1142.6%. Its consensus target price is $10.50 based on the average of all estimates. Alpha Pro Tech, Ltd. (AMEX:APT) has the 2nd highest upside potential in this segment of the market. Its upside is 567.9%. Its consensus target price is $8.75 based on the average of all estimates. Pressure BioSciences, Inc. (NASDAQ:PBIO) has the 3rd highest upside potential in this segment of the market. Its upside is 354.5%. Its consensus target price is $5.00 based on the average of all estimates.NeuroMetrix, Inc. (NASDAQ:NURO) has the 4th highest upside potential in this segment of the market. Its upside is 320.0%. Its consensus target price is $2.16 based on the average of all estimates. MELA Sciences, Inc. (NASDAQ:MELA) has the 5th highest upside potential in this segment of the market. Its upside is 209.0%. Its consensus target price is $11.00 based on the average of all estimates.
Derma Sciences, Inc. (NASDAQ:DSCI) has the 6th highest upside potential in this segment of the market. Its upside is 171.2%. Its consensus target price is $25.00 based on the average of all estimates. WorldHeart Corporation (USA) (NASDAQ:WHRT) has the 7th highest upside potential in this segment of the market. Its upside is 145.9%. Its consensus target price is $3.00 based on the average of all estimates.Vision-Sciences, Inc. (NASDAQ:VSCI) has the 8th highest upside potential in this segment of the market. Its upside is 121.4%. Its consensus target price is $6.00 based on the average of all estimates. IsoRay, Inc. (AMEX:ISR) has the 9th highest upside potential in this segment of the market. Its upside is 111.9%. Its consensus target price is $2.50 based on the average of all estimates. iCAD, INC. (NASDAQ:ICAD) has the 10th highest upside potential in this segment of the market. Its upside is 108.3%. Its consensus target price is $2.50 based on the average of all estimates.
No comments:
Post a Comment